Related Experiment Video
Updated: Aug 11, 2025

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
[Susceptible mechanisms of pulmonary mucormycosis in diabetic patients]
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.
Abstract:
Pulmonary mucormycosis is a rare pulmonary fungal infectious disease. Domestic and international studies have shown that diabetes is the most common underlying condition of this disease, especially with poor glycemic control and diabetic ketoacidosis. The susceptible mechanisms of pulmonary mucormycosis in diabetic patients are closely related to hyperglycemia and diabetic ketoacidosis-induced internal environment alterations. The detailed pathogenesis includes respiratory epithelial cell damage, vascular endothelial injury, immune cell dysfunction, coagulation abnormalities, iron-rich, and high keto-acid environment in diabetic patients. Pulmonary mucormycosis always presents atypical manifestations with rapid progress and poor prognosis in patients with diabetes. This article reviews the recent research progress in the susceptible mechanisms of pulmonary mucormycosis in patients with diabetes.
Insights
Pulmonary mucormycosis, a rare fungal infection, frequently affects diabetic patients due to hyperglycemia and ketoacidosis. This review explores the mechanisms making diabetics susceptible to this severe lung disease.
Area of Science:
- Pulmonology
- Mycology
- Endocrinology
Background:
- Pulmonary mucormycosis is a rare, severe fungal infection.
- Diabetes mellitus, particularly with poor glycemic control and diabetic ketoacidosis, is the most common comorbidity.
Approach:
- This review synthesizes current research on the mechanisms underlying pulmonary mucormycosis susceptibility in diabetic patients.
- Focuses on how hyperglycemia and diabetic ketoacidosis alter the internal environment.
Key Points:
- Diabetic patients exhibit altered pathogenesis including epithelial damage, endothelial injury, immune dysfunction, and coagulation issues.
- A high-ketoacid, iron-rich environment in diabetics promotes fungal growth.
- Pulmonary mucormycosis in diabetics often presents atypically with rapid progression and poor outcomes.
Conclusions:
- Understanding these mechanisms is crucial for improving diagnosis and treatment of pulmonary mucormycosis in diabetic populations.
- Further research into these specific pathogenic pathways can guide therapeutic strategies.
Related Concept Videos
Fungal Group Zygomycota
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Fungal Phylum Microsporidia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

